Back to Companies
Fulcrum Therapeutics, Inc.
FULCNasdaqCIK: 0001680581
Over the 15 most recent insider filings, Fulcrum Therapeutics, Inc. (FULC) has seen activity from 10 distinct insiders — 1 buying and 4 selling. The activity is heavily weighted toward selling: $1.5M bought versus $58.8M sold, net sales of $57.3M. RA CAPITAL MANAGEMENT, L.P. is the most active by dollar volume, and the single largest transaction was $58.4M by RA CAPITAL MANAGEMENT, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$71.8M
Purchases
$1.5M
Sales
$58.8M
Unique Insiders
10
Recent Insider Trades
15 loaded
| Jul 20 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN | Insider | Buy | $594.7K |
| Jul 15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN | Insider | Buy | $891.1K |
| Jul 15 | FULC Fulcrum Therapeutics, Inc. | TANG KEVIN | Insider | Other | $0 |
| Jul 2 | FULC Fulcrum Therapeutics, Inc. | Dorton Katina | Insider | Award | $117.1K |
| Jul 2 | FULC Fulcrum Therapeutics, Inc. | Gould Robert J | Insider | Award | $117.1K |
| Jun 30 | FULC Fulcrum Therapeutics, Inc. | Ezekowitz Alan | Insider | Sell | $65.6K |
| May 1 | FULC Fulcrum Therapeutics, Inc. | Lehrer-Graiwer Joshua | Insider | Other | $0 |
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Sapir Alex | Insider | Award | $7.0M |
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Gould Robert J | Insider | Sell | $160.9K |
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Oltmans Curtis Gale | Insider | Award | $1.8M |
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Tourangeau Greg | Insider | Award | $611.0K |
| Feb 4 | FULC Fulcrum Therapeutics, Inc. | Musso Alan A | Insider | Award | $1.8M |
| Dec 17 | FULC Fulcrum Therapeutics, Inc. | Oltmans Curtis Gale | Insider | Sell | $44.6K |
| Dec 10 | FULC Fulcrum Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Sell | $58.4M |
| Nov 21 | FULC Fulcrum Therapeutics, Inc. | Gould Robert J | Insider | Sell | $165.5K |
15 filings